168 related articles for article (PubMed ID: 6443167)
1. The value of thiotepa in the treatment of superficial bladder tumors.
Akdaş A; Kirkali Z; Sengör F; Ilker Y; Taşar C
Turk J Pediatr; 1984; 26(1-4):243-50. PubMed ID: 6443167
[No Abstract] [Full Text] [Related]
2. Management of superficial bladder carcinoma with BCG. Long term follow-up.
Martínez-Piñeiro JA
Prog Clin Biol Res; 1984; 162B():335-45. PubMed ID: 6438642
[No Abstract] [Full Text] [Related]
3. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
4. [Cytostatic prophylactic treatment of superficial bladder tumours].
Lunglmayr G
Urologe A; 1972 Mar; 11(2):94-7. PubMed ID: 4623214
[No Abstract] [Full Text] [Related]
5. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
Toulouse J; Bouffier B; Etievent JP; Bittard M
J Urol (Paris); 1983; 89(2):85-9. PubMed ID: 6408192
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of postoperative recurrence of bladder cancer: a clinical study].
Yang D; Li S; Wang H; Li X; Liu S; Han W; Hao J; Zhang H
Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):464-5. PubMed ID: 11829890
[TBL] [Abstract][Full Text] [Related]
7. The management of superficial bladder cancer.
Soloway MS
Cancer; 1980 Apr; 45(7 Suppl):1856-65. PubMed ID: 6768441
[No Abstract] [Full Text] [Related]
8. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
9. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
[TBL] [Abstract][Full Text] [Related]
10. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
Corrado F; Lalanne G; Pizza GC
Panminerva Med; 1974 Mar; 16(3):85-91. PubMed ID: 4217438
[No Abstract] [Full Text] [Related]
11. [Prognostic factors and risk of recurrence in a series of 385 patients with superficial bladder carcinoma treated with thiotepa, adriamycin or cisplatin].
Llopis B; Sánchez A; Boronat F; Gallego J; Moreno B; Alonso M; Martínez R; Vera CD; Jiménez JF
Arch Esp Urol; 1987 Apr; 40(3):159-64. PubMed ID: 3113347
[No Abstract] [Full Text] [Related]
12. Use of intravesical thiotepa in superficial bladder tumours.
Kulkarni JN; Kamat MR; Juvekar RL
Indian J Cancer; 1981 Sep; 18(3):222-4. PubMed ID: 6796504
[No Abstract] [Full Text] [Related]
13. Intravesical treatment with thiotepa: an update review.
Fosså SD
Prog Clin Biol Res; 1984; 162B():163-8. PubMed ID: 6438640
[No Abstract] [Full Text] [Related]
14. [Clinical-experience with thiotepa in the treatment of bladder cancer].
Gallo FJ; Menéndez-Ondina L; Matallana A; Bonilla JA; Serrano E; Carballido JA; Mendoza A
Actas Urol Esp; 1978; 2(5):237-40. PubMed ID: 103371
[No Abstract] [Full Text] [Related]
15. [Thio-tepa in the prevention of recurrences of papillary bladder tumors].
Kierfeld G; Mellin P
Z Urol Nephrol; 1973 Aug; 66(8):569-72. PubMed ID: 4204011
[No Abstract] [Full Text] [Related]
16. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
[No Abstract] [Full Text] [Related]
17. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C
Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633
[No Abstract] [Full Text] [Related]
18. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
Schwaibold H; Klingenberger HJ; Huland H
Urologe A; 1994 Nov; 33(6):479-83. PubMed ID: 7817443
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
Goebell PJ; Otto T; Suhr J; Rübben H
J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
[TBL] [Abstract][Full Text] [Related]
20. [Adrianycin as intracavitary coadjuvant treatment of superficial bladder tumors. Our initial experiences].
Martínez Lasierra M; Caro Cebrián C; Sanz Vélez JI; Roncalés A; Rioja Sanz C
Actas Urol Esp; 1981; 5(4):219-22. PubMed ID: 6797270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
